However, as shown in Figure 8A–C, X22 treatment had a protective effect in HFD‐induced cardiac remodelling and also significantly inhibited the mRNA expression of ANP and BNP, suggesting that X22 prevents the development of cardiac hypertrophy in HFD‐fed rats. The gene discussed is NPPB; the disease is cardiac hypertrophy.